Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study

Authors

M.A. Perrouin Verbe, Nantes Université, Nantes, France
C. Goudelocke, Oschner Medical Center, New Orleans, LA
K. Xavier, Urology Partners of North Texas, Arlington, TX
B. Pecha, First Urology, Jeffersonville IN
K. Burgess, Prisma Health, Greenville
Ryan Krlin, LSU Health Sciences Center - New OrleansFollow
J. Michaels, Center for Continence Care, Minnesota Urology, Woodbury
S. Shah, East Coast Institute for Research LLC, Jacksonville FL
B. Peyronnet, Centre Hospitalier Universitaire de Rennes, Rennes, France
S. Zaslau, West Virginia University, Morgantown
K. Noel, Medtronic, Minneapolis MN
D.U.J. Keller, Medtronic, Tolochenaz, Switzerland
D. Elterman, University of Toronto, Canada
V. Nitti, University of California, Los Angeles

Document Type

Conference Proceeding

Publication Date

3-5-2024

Publication Title

European Urology

Abstract

EAU24 - 39th Annual EAU Congress

First Page

S1782

Last Page

S1783

Volume

85

Issue

Supplement 1

Comments

Abstract A0788

Recommended Citation

Perrouin Verbe, M.A.; Goudelocke, C.; Xavier, K.; Pecha, B.; Burgess, K.; Krlin, Ryan; Michaels, J.; Shah, S.; Peyronnet, B.; Zaslau, S.; Noel, K.; Keller, D.U.J.; Elterman, D.; and Nitti, V., "Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study" (2024). School of Medicine Faculty Publications. 2626.
https://digitalscholar.lsuhsc.edu/som_facpubs/2626
10.1016/S0302-2838(24)01359-9